Click here for more information about this title
Series |
Infectious disease Infectious disease (Totowa, N.J.) ^A530666
|
Contents |
Department of defense capabilities supporting bioterrorism response -- Modeling for bioterrorism incidents -- Biological weapons defense: effect levels -- Pathogenesis by aerosol -- Bacillus anthracis and the pathogenesis of anthrax -- Virologic and pathogenic aspects of the variola virus (Smallpox) as a bioweapon -- Plague vaccines: retrospective analysis and future developments -- Medical protection against brucellosis -- Pathogenesis of and immunity to coxiella burnetii -- Glanders: new insights into an old disease -- Medical countermeasures for filoviruses and other viral agents -- Medical defense against protein toxin weapons: review and perspective -- Antimicrobials for biological warfare agents -- Nonspecific immunomodulator therapy: CpG -- Decontamination -- Definition and overview of emerging threats -- Department of defense global emerging infections system programs in biodefense -- Information resources and database development for defense against biological weapons -- Genomic efforts with biodefense pathogens -- Genomics for biodefense: exploiting the francisella tularensis genome sequence -- Genetic fingerprinting of biodefense pathogens for epidemiology and forensic investigation -- Yersinia pestis as an emerged pathogen: what lessons can be learned? -- Requirements for biological threat identification systems -- DNA-based diagnostic tests for detection and identification of biological weapons -- Concepts for the development of immunodiagnostic assays for detection and diagnosis of biothreat agents. |
Bibliography note | Includes bibliographical references and index. |
LCCN | 2004004125 |
ISBN | 1588291847 : |